Improving biocontainment capabilities for infectious disease research
Resources and Workforce Development for the Tulane Regional Biocontainment Laboratory
This study is working to improve a special lab that helps scientists learn more about serious diseases like COVID-19, so they can quickly find better treatments and vaccines that could help people in the future.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Tulane University of Louisiana NIH-funded |
| Lab location | 1 site (New Orleans, United States) |
| Project ID | NIH-10912064 on NIH RePORTER |
What this research studies
This research focuses on enhancing the capabilities of the Tulane Regional Biocontainment Laboratory (RBL) to study high-consequence pathogens, particularly in the context of emerging infectious diseases like COVID-19. By fortifying the infrastructure and resources available at the laboratory, the project aims to ensure a rapid and effective response to public health threats. The research involves strategic planning and development to support in vivo studies using nonhuman primates, which are critical for understanding and combating infectious diseases. Patients may benefit indirectly through advancements in treatments and vaccines developed from this research.
Who could benefit from this research
Good fit: Ideal candidates for benefiting from this research include individuals affected by or at risk for emerging infectious diseases, particularly those related to COVID-19.
Not a fit: Patients with non-infectious diseases or those not impacted by emerging infectious diseases may not receive direct benefits from this research.
Why it matters
Potential benefit: If successful, this research could lead to improved treatments and preventive measures for infectious diseases affecting human health.
How similar studies have performed: Other research initiatives focused on enhancing biocontainment and infectious disease response have shown promise, particularly during the COVID-19 pandemic, indicating a potential for success in this area.
Where this research is happening
New Orleans, United States
- Tulane University of Louisiana — New Orleans, United States (Active)
Researchers
- Principal investigator: Rappaport, Jay — Tulane University of Louisiana
- Study coordinator: Rappaport, Jay
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.